AIM ImmunoTech Stock Forecast

AIM's stock price has decreased by -95.93% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 analysts polled by S&P Global, AIM ImmunoTech stock has a consensus rating of "Buy" and an average price target of $5.25. The average 1-year stock price forecast is 1,345.88% higher than the current stock price, while the lowest is $1.50 (+313.11%) and the highest is $9.00 (+2,378.66%).

Price Target: $5.25 (+1,345.88%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.50	$5.25	$5.25	$9.00
Change	+313.11%	+1345.9%	+1345.9%	+2378.7%

Analyst Ratings

The average analyst rating for AIM ImmunoTech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Dec '25	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	0	0	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	1	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Buy Reiterates $1.5	Buy	Reiterates	$1.5	+313.11%	Jun 2, 2026
Edward Woo Ascendiant	Ascendiant	Buy Maintains $10 → $9	Buy	Maintains	$10 → $9	+2,378.66%	May 31, 2026

Financial Forecast

Revenue This Year

61.00K

from 88.00K

-30.68%

from 88.00K

Revenue Next Year

50.00K

from 61.00K

-18.03%

from 61.00K

EPS This Year

-0.63

from -8.62

EPS Next Year

-0.52

from -0.63

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	135.00K	141.00K	202.00K	170.00K	88.00K	61.00K
Revenue Growth	-17.18%	4.44%	43.26%	-15.84%	-48.24%	-30.68%
Gross Profit	-715.00K	141.00K	160.00K	139.00K	-40.00K	44.53K
Gross Margin	-529.63%	100.00%	79.21%	81.76%	-45.45%	73.00%
Operating Income	-17.06M	-19.92M	-31.92M	-19.77M	-11.66M	-10.85M
Net Income	-19.13M	-19.45M	-28.96M	-17.32M	-13.96M	-11.84M
EPS	-	-	-	-	-8.62	-0.63
Free Cash Flow	-9.77M	-11.15M	-12.16M	-12.20M	-11.97M	128.27M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	100,000
Avg	61,000
Low	22,000

Revenue Growth

Revenue Growth	2026	2027	2028
High	13.6%
Avg	-30.7%
Low	-75.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.63
Avg	-0.63
Low	-0.63

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-